Hepatitis b virus core and e antigen: Immune recognition and use as a vaccine carrier moiety

Intervirology

Volumn 39, Issue 1-2, 1996, Pages 104-110

  Schodel F ^a   Peterson, D ^b   Milich, D ^c  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Circumsporozoite antigen; Core particles; Epitope presentation; HBcAg; HbeAg; Hepatitis B virus; Malaria; Malaria vaccine

Indexed keywords

CORE PROTEIN; DRUG CARRIER; FREUND ADJUVANT; HEPATITIS B CORE ANTIGEN; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN G; VACCINE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ANTIGENICITY; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; HELPER CELL; HEPATITIS B VIRUS; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TRANSGENIC MOUSE; VIRUS TRANSMISSION;

ANIMALS; ANTIGENS, PROTOZOAN; EPITOPES; GENETIC VECTORS; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNOGENETICS; PLASMODIUM; PROTOZOAN PROTEINS; VACCINES; VACCINES, SYNTHETIC;

ANIMALIA; HEPATITIS B VIRUS; MURINAE; MUS MUSCULUS; PLASMODIUM FALCIPARUM; RODENTIA;

EID: 0029799729     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000150481     Document Type: Article

References (48)

1. McLachlan A (ed): Molecular Biology of Hepatitis B Virus, Boca Raton, CRC Press, 1991.
2. Crowther RA, Kiselev NA, Bdttcher B, Berri-man JA, Borisova GP, Ose V, Pumpens P: Three-dimensional structure of hepatitis B virus core particles determined by electron microscopy, Cell 1994:77:943-950.
3. Milich DR: T and B cell recognition of hepatitis B virus antigens, Immunol Today 1988:9: 380-386.
4. Schodel F, Peterson D, Hughes J, Milich DR: Hepatitis B virus core particles as a vaccine carrier moiety, Int Rev Immunol 1994; 11:153- 164.
5. Ou JH, Laub O, Rutter WJ: Hepatitis B virus gene function: The precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen, Proc Natl Acad Sci USA 1986:83:1578-1582.
6. Roossinck MJS, Jameel S, Loukin SH, Siddi-qui A: Expression of hepatitis B viral core gene in mammalian cells, Mol Cell Biol 1986:6: 1393.
7. McLachlan A, Milich DR, Raney AK, Riggs MG, Hughes JL, Sorgc J, Chisari FV: Expression of hepatitis B virus surface and core antigens: Influences of pre-S and precore sequences, J Virol 1987:61:683-692.
8. Weimer T, Salfeld J, Will H: Expression of the hepatitis B virus core gene in vitro and in vivo, J Virol 1987;61:3750-3113.
9. Bruss V, Gcrlich W: Formation of a transmcm-brancous hepatitis B e antigen by cotranslation-al in vivo processing of the viral precore protein, Virology 1988:163:268-275.
10. Jcan-Jean O, Levrero M, Will H, Pcrricaudet J, Rossignol J-M: Expression of the hepatitis B virus (HBV) C gene and biosynthesis of HBe antigen, Virology 1989:170:99-106.
11. Takahashi K, Machida A, Funatsu G, Nomura M, Usuda S, Aoyagi S, Tachibana K, Miyamoto H, Imai M, Nakamura T, Miyakawa Y, Mayumi M: Immunochemical structure of hepatitis e antigen in the scrum, J Immunol 1983: 130:2903-2907.
12. Standring DN, Ou J-H, Masiarz RR, Rultcr WJ: A signal peptide encoded within the pre-core region of hepatitis-B virus directs the secretion of a heterogeneous population of e-anti-gens in xenopus oocytes, Proc Natl Acad Sci USA 1988:85:8405-8409.
13. Schodel F, Peterson D, Zheng J, Jones JE, Hughes JL, Milich DR: Structure of hepatitis B virus core and e-antigen: A single precorc amino acid prevents nucclocapsid assembly, J Biol Chem 1993:268:1332-1337.
14. Wasenauer G, Rock J, Schlicht HJ: A cysteine and a hydrophobic sequence in the noncleavcd portion of the prc-c leader peptide determine the biophysical properties of the secretory core protein (hbe protein) of human hepatitis B virus, J Virol 1992.66:5338-5346.
15. Nassal M, Rieger A: An intramolecular disulfide bridge between cys-7 and cys61 determines the structure of the secretory core gene-product (e-antigen) of hepatitis B virus, J Virol 1993:67:1315.
16. Milich DR, Jones J, Hughes J, Mayumara T: Hepatitis B virus infection, the immune response and hepatocellular carcinoma, Ciba Found Symp 1994; 187:113-131.
17. Salfcld J, Pfaff E, Noah M, Schaller H: Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus, J Virol 1989:63:798-808.
18. Schodel F, Moriarty AM, Peterson DL, Zheng J, Hughes JL, Will H, Leturcq DJ, McGee JS, Milich DR: The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity, J Virol 1992;66:106-114.
19. Maruyama T, Schodel F, lino S, Koike K, Ya-suda K, Peterson D, Milich DR: Distinguishing between acute and symptomatic chronic hepatitis B virus infection, Gastroenterology 1994: 106:1006.
20. Milich DR, McLachlan A, Moriarty A, Thornton GB: Immune responses to hepatitis B virus core antigen (HBcAg): Localization of T cell recognition sites within HBcAg/HBeAg, J Immunol 1987:139:1223.
21. Ferrari C, Bertoletti A, Penna A, Cavalli A, Missalc G, Pilli M, Fowler P, Giubcrti T, Chi-sari FV, Fiaccadori F: Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen, J Clin Invest 1991: 88:214-222.
22. Jung M-C, Diepolder HM, Spengler U, Wic-renga EA, Zachoval R, Hoffmann RM, Eichen-laub D, Frosner G, Will H, Pape GR: Activation of a heterogeneous hepatitis B (HB) core and e antigen specific CD4+ T-ccll population during seroconversion to anti-HBe and anti HBs in hepatitis B virus infection, J Virol 1995: 69:3358-3368.
23. Missale G, Redeker A, Person J, Fowler P, Guilhot S, Schlicht HJ, Vitiello A, Chesnul C, Fiaccadori F, Ferrari C: HLA-A31 and FILA-Aw68 restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis, J Exp Med 1993; 177:751-762.
24. Bertoletti A, Chisari FV, Penna A, Guilhot S, Galati L, Missalc G, Fowler P, Schlicht H-J, Vitiello A, Chesnut RC, Fiaccadori F, Ferrari C: Definition of a minimal optimal cytotoxic T cell epitope within the hepatitis B virus nuclco-capsid protein, J Virol 1993:67:2376-2380.
25. Bertoletti A, Sctte A, Scaccaglia P, Lcvrero M, Chisari GV, Fiaccadori F, Ferrari C: Natural variants of cytotoxic T epitopes are T cell receptor antagonists for antiviral cytotoxic T cells, Nature 1994:369:407-410.
26. Milich DR, McLachlan A: The nucleocapsid of the hepatitis B virus is both a T-cell independent and a T-cell dependent antigen, Science 1986:234:1398.
27. Milich DR, McLachlan A, Thornton GB, Hughes JL: Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site, Nature 1987:329:547-549.
28. Murray K, Bruce SA, Hinncn A, Wingfield P, van Erd PMCA, de Reus A, Schcllckens H: Hepatitis-B virus-antigens made in microbial cells immunize against viral infection, EMBO J 1984:3:645-650.
29. Schodel F, Neckermann G, Peterson D, Fuchs K, Fuller S, Will H, Roggendorf M: Immunization with recombinant woodchuck hepatitis virus nucleocapsid antigen or hepatitis B virus nucleocapsid antigen protects woodchucks from woodchuck hepatitis virus infection, Vaccine 1994:11:624-628.
30. Maruyama T, McLachlan A, lino S, Koike K, Kurokawa K, Milich DR: The serology of chronic hepatitis B infection revisited, J Clin Invest 1993:91:2586.
31. Brunetto MR, Stemler M, Schodel F, Will H, Ottobrelli A, Rizzetto M, Verme G, Bonino F: Identification of HB variants which cannot produce precorc derived HBeAg and may be responsible for severe hepatitis, Ital J Gastroenterol 1989;21:151-154.
32. Carman WF, Jacyna MR, Hadziyannis S, Ka-raviannis P, McGarvey MJ, Makris A, Thomas HC: Mutation preventing formation of hepatitis Be antigen in patients with chronic hepatitis B infection, lancet 1989;ii:588-590.
33. Okamoto H, Yotsumoto S, Akahane Y, Yania-naka T, Miyazaki Y, Sugai Y, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M: Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen, J Virol 1990;64:1298-1303.
34. Schlicht HJ, Salfeld J, Schaller H: The duck hepatitis B virus pre-C region encodes a signal sequence which is essential for synthesis and secretion of processed core proteins but not for virus formation, J Virol 1987;61:2208-2212.
35. Chang C, Endcrs G, Sprcngcl RE, Peters N, Varmus H, Ganem D: Expression of the precore region of an avian hepatitis B virus is not required for viral replication, J Virol 1987:61: 3322-3325.
36. Liang TJ, Hascgawa K, Rimon N, Wands JR, Ben-Porath E: A hepatitis B-virus mutant associated with an epidemic offulminant-hepatitis, NEnglJ Med 1991;324:1705-1709.
37. Kojinta Y, Shimizu M, Tsuchimochi T, Koyasu M, Tanaka S, Iizuka H, Tanaka K, Okamoto H, Tsuda F, Miyakawa Y, Mayumi M: Posttransfusion fulminant hepatitis B associated with precore-defective HBV mutants, Vox Sang 1991:60:34-39.
38. Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A: Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci USA 1990:87:6599-6603.
39. Milich DR, Hughes JL, Houghton R, McLachlan A, Jones JE: Functional identification of agrctopic and epitopic residues within an HBcAg T cell determinant, J Immunol 1989: 143:3141-3147.
40. Milich DR, McLachlan A, Raney AK, Hough-ten R, Thornton GB, Maruyama T, Hugltes-Joncs JE: Autoantibody production in hepatitis B c antigen transgenic mice elicited with a self T-ccll peptide and inhibited with nonself peptides, Proc Natl Acad Sci USA 1991:88:4348-4352.
41. Milich DR, Schödel F, Peterson DL, Jones JE, Hughes JL: Characterization of self-reactive T cells that evade tolerance in hepatitis B e antigen transgenic mice, Eur J Immunol 1995:25: 1663-1672.
42. Schödel F, Wirtz R, Peterson D, Hughes J, Warren R, Sadoff J, Milich D: Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes, J Exp Med 1994:180:1037-1046.
43. Schodel F, Peterson D, Charoenvit Y, Sadol TJ, Wirtz R: Immunity to Plasmodium yoelii infec-tion elicited by hybrid hepatitis B virus core particles (HBcAg) carrying circumsporozoite antigen epitopes, 95th ASM General Meeting, Washington, 1995, abstr E61.
44. Schödel F, Kelly S, Tinge S, Hopkins S, Peterson D, Curtiss R: Hybrid hepatitis B virus core antigens as a vaccine carrier moiety, II, Expression in avirulent Salmonella spp, for mucosal immunization: in Shafferman A, Cohen S (eds): Vaccines: Novel Strategies in Design and Production, Proc 39th OHOLO Conf, 1995, New York, Plenum, in press.
45. Clarke BE, Newton SE, Carroll AR, Francis MJ, Appleyard G, Syred D, Highfield PE, Rowlands DJ, Brown F: Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein, Nature 1987:330:381 - 384.
46. Charoenvit Y, Mellouk S, Cole C, Bcchara R, Leef MF, Sedegah M, Yuan LF, Robey FA, Beaudoin RL, Hoffman S: Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites, Infect Immun 1991: 146:1020-1025.
47. Herzenberg LA, Tokuhisa T: Epitope-specific regulation, I, Carrier-specific induction of suppression for lgG anti-hapten antibody response, J Exp Med 1983:155:1730.
48. Borisova G, Biragyn A, Dislers A, Borschukova O, Tsibinogin V, Skrastina D, Eldarov MA, Pumpcns P, Skryabin KG, Grens E: Hybrid hepatitis B virus nucleocapsid bearing an immunodominant region from hepatitis-B virus surfacc-antigen, J Virol 1993;67:3696-3701.